Company Filing History:
Years Active: 2022-2025
Title: The Innovative Contributions of Cecile Pegurier
Introduction
Cecile Pegurier is a notable inventor based in Uccle, Belgium. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target GPR17-associated disorders. With a total of 6 patents to her name, her work is recognized for its potential therapeutic applications.
Latest Patents
Cecile's latest patents include "Substituted alkoxypyridinyl indolsulfonamides" and "Pyridinyl and pyrazinyl-(aza)indolsulfonamides." The first patent relates to alkoxy-substituted pyridinyl indolsulfonamides, which act as negative GPR17 modulators. These compounds have utility in treating various disorders associated with GPR17. The second patent focuses on pyridinyl and pyrazinyl-(aza)indolsulfonamides, which also exhibit GPR17 modulator activity and have potential applications in treating a variety of related disorders.
Career Highlights
Cecile Pegurier is currently employed at UCB Pharma GmbH, where she continues to innovate and contribute to the pharmaceutical industry. Her work is characterized by a strong focus on developing new therapeutic agents that can address unmet medical needs.
Collaborations
Cecile collaborates with esteemed colleagues such as Laurent Provins and Marie Ledecq. These partnerships enhance her research and development efforts, fostering an environment of innovation and creativity.
Conclusion
Cecile Pegurier's contributions to the field of pharmaceuticals through her patents and collaborations highlight her role as a significant inventor. Her work in developing GPR17 modulators showcases the potential for innovative treatments in addressing complex medical conditions.